Sobin Kim

Sobin is the Chief Technology Officer of OncoPep. She leads research and development of OncoPep as well as oversees scientific and technological plans to ensure that they’re in line with the growth objectives of the company. She also examines the short- and long-term technological targets and designs solutions to help OncoPep reach those targets.

Prior to joining at OncoPep, Sobin has worked in various academic and industrial positions. She started her professional career as a research scientist at Columbia Genome Center (New York, NY) and developed various gene sequencing technologies. Then she served as an assistant professor in the department of Biomedical Engineering at Rutgers, The State University of New Jersey (New Brunswick, NJ), where she headed a laboratory of functional genomics and conducted biomedical research projects for various diseases including breast cancer. Her most recent role prior to OncoPep was at HuVet bio, Inc (Seoul, South Korea). As the Chief Technology Officer of the company, she led various cancer- and vaccine-projects including discovery of novel biomarker panels for pancreatic cancer, production of blood screening systems for cancer, development of protein subunit vaccines, etc. Moreover, she managed the company’s technological assets and pipelines, and made plans to cultivate the overall R&D infrastructure of the company. She also owns inventorship of several patents.

Sobin obtained a bachelor’s and a master’s degree from the Department of Chemical Technology in Seoul National University (Seoul, South Korea) and a Ph.D. degree from the Department of Chemical Engineering in Columbia University (New York, NY).